Home › Funds › Invenomic Capital Management LP › DLO
Invenomic Capital Management LP position in DLO
DLOCAL LTD · Consumer Discretionary
Invenomic Capital Management LP reported holding 1,395,170 shares of DLO (DLOCAL LTD) in its Q2 2026 13F filing — a position valued at US$18.1M, representing 1.08% of its reported portfolio and ranking #33 among its reported holdings. Invenomic Capital Management LP has disclosed DLO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's DLO position evolved
Invenomic Capital Management LP first disclosed a stake in DLO in Q1 2026 at 255,352 shares (US$3.3M). The position peaked in Q2 2026 at 1,395,170 shares, worth US$18.1M. Across 2 filings, Invenomic Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,395,170 shares valued at US$18.1M — an increase of 1,139,818 shares quarter over quarter.. Notable position changes include a 446% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 255.35K | $3.31M | New |
| Q2 2026 | 1.40M | $18.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DLO and 13F data
DLO (DLOCAL LTD) is a Consumer Discretionary company. 35 other funds we track also report a position in DLO — the largest reported positions include GENERAL ATLANTIC, L.P. (US$606.3M), Summit Trail Advisors, LLC (US$99.8M), Cria, Inc. (US$52.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DLO
- GENERAL ATLANTIC, L.P. 46.66M sh · $606.30M · Q2 2026
- Summit Trail Advisors, LLC 7.68M sh · $99.79M · Q2 2026
- Cria, Inc. 4.00M sh · $51.96M · Q2 2026
- ATMOS CAPITAL GESTAO DE RECURSOS LTDA. 3.99M sh · $51.86M · Q2 2026
- Fourth Sail Capital LP 3.94M sh · $51.24M · Q2 2026
- Ribbit Management Company, LLC 3.89M sh · $50.56M · Q2 2026
- Paradice Investment Management LLC 2.73M sh · $37.58M · Q3 2026
- Tikvah Management LLC 1.42M sh · $18.46M · Q2 2026
- TB Capital Gestao de Recursos Ltda. 1.11M sh · $14.45M · Q2 2026
- Bond Capital Management, LP 927.50K sh · $12.05M · Q2 2026
- Lane Generational LLC 473.69K sh · $6.16M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held DLO?
Invenomic Capital Management LP has disclosed DLO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Invenomic Capital Management LP's current position in DLO?
As of Q2 2026, Invenomic Capital Management LP holds 1.40M shares of DLO (DLOCAL LTD), valued at $18.13M, representing 1.08% of its reported portfolio and ranking #33.
Has Invenomic Capital Management LP been buying or selling DLO?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in DLO. The position peaked in Q2 2026 at 1.40M shares.
Which other funds hold DLO?
Other major institutional holders of DLO include GENERAL ATLANTIC, L.P., Summit Trail Advisors, LLC, Cria, Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.